Literature DB >> 327040

Jejunal mucosal immunoglobulins and complement in untreated coeliac disease.

B B Scott, D G Scott, M S Losowsky.   

Abstract

Jejunal immunofluorescence studies have shown that there is a significantly increased incidence of extracellular IgA and complement in the basement membrane zone and lamina propria of untreated adult coeliac patients compared to coeliac patients on a gluten-free diet. IgG was also demonstrated with complement, particularly in the untreated patients. These findings, taken together with those of other studies, suggest that a local antibody-antigen reaction involving IgA and complement may be responsible for the ongoing mucosal damage in untreated coeliac disease as well as for the acute damage following gluten challenge of the treated patient. Furthermore, consequent upon this damage there may be a secondary IgG antibody response, possibly reticulin antibody, contributing to the mucosal damage.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 327040     DOI: 10.1002/path.1711210405

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  9 in total

1.  PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage.

Authors:  Maria Paola Simula; Renato Cannizzaro; Vincenzo Canzonieri; Alessandro Pavan; Stefania Maiero; Giuseppe Toffoli; Valli De Re
Journal:  Mol Med       Date:  2010-03-03       Impact factor: 6.354

Review 2.  Proteomic analyses lead to a better understanding of celiac disease: focus on epitope recognition and autoantibodies.

Authors:  Valli De Re; Maria Paola Simula; Vincenzo Canzonieri; Renato Cannizzaro
Journal:  Dig Dis Sci       Date:  2010-07-15       Impact factor: 3.199

3.  Complement activation within the coeliac small intestine is localised to Brunner's glands.

Authors:  R B Gallagher; C P Kelly; S Neville; O Sheils; D G Weir; C F Feighery
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

4.  Immunoglobulin secretion by isolated intestinal lymphocytes: spontaneous production and T-cell regulation in normal small intestine and in patients with coeliac disease.

Authors:  J E Crabtree; R V Heatley; M L Losowsky
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

5.  Small intestinal plasma cells in coeliac disease.

Authors:  B B Scott; A Goodall; P Stephenson; D Jenkins
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

6.  Proteins specifically hyperexpressed in a coeliac disease patient with aberrant T cells.

Authors:  V De Re; M P Simula; L Caggiari; N Orzes; M Spina; A Da ponte; L De Appollonia; R Dolcetti; V Canzonieri; R Cannizzaro
Journal:  Clin Exp Immunol       Date:  2007-03-05       Impact factor: 4.330

7.  Complement studies in children with treated coeliac disease after gluten challenge.

Authors:  C Bosch; M Becker; H W Rotthauwe; W Opferkuch
Journal:  Eur J Pediatr       Date:  1980-08       Impact factor: 3.183

8.  Jejunal plasma cells and in vitro immunoglobulin production in adult coeliac disease.

Authors:  G M Wood; P D Howdle; L K Trejdosiewicz; M S Losowsky
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

9.  Gluten-sensitive enteropathy. Immunoglobulin G heavy-chain (Gm) allotypes and the immune response to wheat gliadin.

Authors:  J B Weiss; R K Austin; M S Schanfield; M F Kagnoff
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.